Nektar Therapeutics (NKTR)
1.395
-0.02
(-1.76%)
USD |
NASDAQ |
Apr 24, 16:00
1.39
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Cash from Investing (TTM): 139.56M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 139.56M |
| September 30, 2023 | 162.20M |
| June 30, 2023 | 217.18M |
| March 31, 2023 | 276.16M |
| December 31, 2022 | 365.84M |
| September 30, 2022 | 446.02M |
| June 30, 2022 | 333.79M |
| March 31, 2022 | 322.60M |
| December 31, 2021 | 202.78M |
| September 30, 2021 | 175.32M |
| June 30, 2021 | 224.82M |
| March 31, 2021 | 308.90M |
| December 31, 2020 | 496.21M |
| September 30, 2020 | 538.95M |
| June 30, 2020 | 548.54M |
| March 31, 2020 | 416.79M |
| December 31, 2019 | 206.89M |
| September 30, 2019 | 158.94M |
| June 30, 2019 | -520.58M |
| March 31, 2019 | -1.440B |
| December 31, 2018 | -1.380B |
| September 30, 2018 | -1.444B |
| June 30, 2018 | -903.92M |
| March 31, 2018 | 32.47M |
| December 31, 2017 | -28.81M |
| Date | Value |
|---|---|
| September 30, 2017 | -193.89M |
| June 30, 2017 | -84.82M |
| March 31, 2017 | -131.72M |
| December 31, 2016 | -82.40M |
| September 30, 2016 | 52.50M |
| June 30, 2016 | 29.82M |
| March 31, 2016 | -31.25M |
| December 31, 2015 | -14.34M |
| September 30, 2015 | -31.94M |
| June 30, 2015 | 2.504M |
| March 31, 2015 | 73.80M |
| December 31, 2014 | -37.57M |
| September 30, 2014 | -94.91M |
| June 30, 2014 | -93.28M |
| March 31, 2014 | -51.99M |
| December 31, 2013 | 49.91M |
| September 30, 2013 | 194.29M |
| June 30, 2013 | 147.12M |
| March 31, 2013 | 108.28M |
| December 31, 2012 | 113.02M |
| September 30, 2012 | 65.19M |
| June 30, 2012 | 123.32M |
| March 31, 2012 | 138.36M |
| December 31, 2011 | -111.95M |
| September 30, 2011 | -143.52M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-520.58M
Minimum
Jun 2019
548.54M
Maximum
Jun 2020
264.26M
Average
276.16M
Median
Mar 2023
Cash from Investing (TTM) Benchmarks
| Stereotaxis Inc | 19.76M |
| Vanda Pharmaceuticals Inc | -12.06M |
| Cara Therapeutics Inc | 43.46M |
| Marinus Pharmaceuticals Inc | -28.60M |
| DiaMedica Therapeutics Inc | -18.30M |